Navigation Links
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
Date:5/16/2008

rs and administration site conditions is set forth in the following table:

System Organ Class/Preferred Term ANX-530 Navelbine P value

General Disorders and Administration Site

Conditions 5 14 0.014

Infusion Site Phlebitis 1* 7 -

Asthenia 3 3 -

Fatigue 1 1 -

Infusion Site Irritation 0 1 -

Infusion Site Pruritis 0 1 -

Pyrexia 0 1 -

* One event of infusion site phlebitis was excluded based on its proximity

to an additional dose of Navelbine administered during the study's

follow up period.

A summary of post-hoc analyses regarding injection site reactions is set forth in the following table:

ANX-530 Navelbine P value

Injection Site Reactions 1 9 <0.01

Infusion Site Phlebitis 1 7 0.03

Infusion Site Irritation 0 1 -

Infusion Site Pruritis 0 1 -

General disorders and administration site conditions denotes the system/organ/class MedDRA term. Injection site reactions consist of all grades of investigator-reported phlebitis, irritation and pruritus, in each case at the site of injection. Adverse events were graded based on the investigator's assessment of severity.

The bioequivalence study of ANX-530 was a crossover comparison of ANX-530 and Navelbine with a primary objective of demonstrating the pharmacokinetic equivalence of ANX-530 and Navelbine. Determining the safety o
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
2. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
3. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
4. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
5. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
8. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
9. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
10. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/22/2014)... 2014 The first ORTC Public ... Microsoft, and Google. ( http://ortc.org/wp-content/uploads/2014/08/ortc.html ) , ... to create a WebRTC 1.1 API with exceptional ... WebRTC, ORTC (Object Real-time Communication) enables plugin-free real-time ... specifically tailored to provide the direct control needed ...
(Date:8/22/2014)... California (PRWEB) August 22, 2014 The ... , BillionaireFish.com, recently registered its two millionth member, and ... threshold. , Billionairefish.com is a dating website for ... women to date. The dating website caters like-minded people ... dating site for the rich , this is ...
(Date:8/22/2014)... New York, NY (PRWEB) August 22, 2014 ... at NY Heart Health Clinics are promoting non-invasive ... four most preventable risks of cardiovascular morbidity and ... heart disease, stroke, Deep Vein Thrombosis and Pulmonary ... Health Clinics are promoting painless, noninvasive screening at ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... , The US FDA announced on August 19, that ... Systems, model number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular ... defective saline sheaths that could fracture during use and ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The Berkowitz ... behalf of a client who suffered severe, permanent injuries ... old drunk driver (docket number FST-CV13-6018309-S). The case was ... mediation. , According to Jennifer Amdur of The Berkowitz ... the case, all of whom were allegedly ...
Breaking Medicine News(10 mins):Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 2Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 3Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 2Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:The Berkowitz Law Firm LLC Reaches a $2 Million Settlement for a Client Allegedly Injured in Drunk Driving Accident 2
... Calif., June 5 The Service Employees,International Union ... attack on Sen. Barack Obama,s healthcare plan as ... registered nurses, the,California Nurses Association/National Nurses Organizing Committee ... this week, SEIU blasts CNA/NNOC for,supporting a "government-run ...
... Officials at,Southern Research Institute, a not-for-profit ... the areas of preclinical drug discovery, drug,and ... today announced that Charles D. McCrary, President ... has joined the company,s Board,of Directors., ...
... these foods may also counteract damage tobacco does to ... -- Eating fruits and vegetables rich in flavonoids and ... say researchers from the University of California, Los Angeles ... antioxidant and anti-inflammatory properties that can counteract damage to ...
... retail drug,store sales for the four-week and seventeen-week periods ended May 29,2008., ... Periods ended May 29, 2008 ... Month Year to Date (Dollars in millions) ... (17 weeks), Total retail drug store sales ...
... June 5 Universal Health,Realty Income Trust (NYSE: ... to increase the quarterly dividend by $.005 and pay ... to shareholders of record as of June 16,2008., ... trust,invests in healthcare and human service related facilities including ...
... fat metabolism , , THURSDAY, June 5 (HealthDay News) -- ... familiar to the diet-conscious choosing between carrots and carrot ... just a matter of what you put in your ... predisposed to process fat. , The theory is based ...
Cached Medicine News:Health News:Service Employee Union's Latest Attack on RNs Parrots McCain's Attack on Obama's Health Plan 2Health News:Service Employee Union's Latest Attack on RNs Parrots McCain's Attack on Obama's Health Plan 3Health News:Charles D. McCrary Joins Southern Research Institute Board of Directors 2Health News:Fruits, Vegetables, Teas May Cut Smokers' Cancer Risk 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:Weight Gain May Not Be Based Just on What You Eat 2Health News:Weight Gain May Not Be Based Just on What You Eat 3
... all silicone cuff is totally ... dimension to the outer diameter ... it can be partially or ... management needs. TTS™ is the ...
... The forgiving nature of the silicone ... range of mobility and more comfort than ... ,The soft, comfortable and compliant neck ... with minimal stoma irritation. A comprehensive range ...
... (TTS™) cuff facilitates stomal insertion., ,Adult ... include a trach tie, disconnect wedge, and ... tracheostomy tubes are intended for temporary use ... tube can be obtained. Not for home ...
... termination for easy ventilator circuit attachment with ... ,Clearly the softer choice in a ... ,The Portex® flexible disposable inner cannula tracheostomy ... providing a softer and more pliable tube ...
Medicine Products: